These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10970403)

  • 21. Multi-centre evaluation of the Etest method for antifungal drug susceptibility testing of Candida spp. and Cryptococcus neoformans. BSAC Working Party on Antifungal Chemotherapy.
    Warnock DW; Johnson EM; Rogers TR
    J Antimicrob Chemother; 1998 Sep; 42(3):321-31. PubMed ID: 9786472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of broth macrodilution and microdilution techniques for in vitro antifungal susceptibility testing of yeasts by using the National Committee for Clinical Laboratory Standards' proposed standard.
    Barchiesi F; Colombo AL; McGough DA; Rinaldi MG
    J Clin Microbiol; 1994 Oct; 32(10):2494-500. PubMed ID: 7814488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of visual 24-hour and spectrophotometric 48-hour MICs to CLSI reference microdilution MICs of fluconazole, itraconazole, posaconazole, and voriconazole for Candida spp.: a collaborative study.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Fothergill A; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Sep; 43(9):4535-40. PubMed ID: 16145103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of Etest and a tablet diffusion test with the NCCLS broth microdilution method for fluconazole and amphotericin B susceptibility testing of Candida isolates.
    Arendrup M; Lundgren B; Jensen IM; Hansen BS; Frimodt-Møller N
    J Antimicrob Chemother; 2001 May; 47(5):521-6. PubMed ID: 11328761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of FUNGITEST and broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
    Davey KG; Holmes AD; Johnson EM; Szekely A; Warnock DW
    J Clin Microbiol; 1998 Apr; 36(4):926-30. PubMed ID: 9542910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical evaluation of the Sensititre YeastOne colorimetric antifungal plate for antifungal susceptibility testing of the new triazoles voriconazole, posaconazole, and ravuconazole.
    Pfaller MA; Espinel-Ingroff A; Jones RN
    J Clin Microbiol; 2004 Oct; 42(10):4577-80. PubMed ID: 15472311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of candida species.
    Cuenca-Estrella M; Lee-Yang W; Ciblak MA; Arthington-Skaggs BA; Mellado E; Warnock DW; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3644-7. PubMed ID: 12384382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multicenter comparison of the Sensititre YeastOne colorimetric antifungal panel with the NCCLS M27-A2 reference method for testing new antifungal agents against clinical isolates of Candida spp.
    Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Holliday N; Killian SB
    J Clin Microbiol; 2004 Feb; 42(2):718-21. PubMed ID: 14766842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selection of candidate quality control isolates and tentative quality control ranges for in vitro susceptibility testing of yeast isolates by National Committee for Clinical Laboratory Standards proposed standard methods.
    Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG
    J Clin Microbiol; 1994 Jul; 32(7):1650-3. PubMed ID: 7929752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates.
    Koehling HL; Willinger B; Buer J; Rath PM; Steinmann J
    J Clin Microbiol; 2015 Jan; 53(1):255-61. PubMed ID: 25392352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of a new commercial colorimetric microdilution method with a standard method for in-vitro susceptibility testing of Candida spp. and Cryptococcus neoformans.
    Davey KG; Szekely A; Johnson EM; Warnock DW
    J Antimicrob Chemother; 1998 Oct; 42(4):439-44. PubMed ID: 9818741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of fluconazole as a surrogate marker to predict susceptibility and resistance to voriconazole among 13,338 clinical isolates of Candida spp. Tested by clinical and laboratory standards institute-recommended broth microdilution methods.
    Pfaller MA; Messer SA; Boyken L; Rice C; Tendolkar S; Hollis RJ; Diekema DJ
    J Clin Microbiol; 2007 Jan; 45(1):70-5. PubMed ID: 17079501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents.
    Alexander BD; Byrne TC; Smith KL; Hanson KE; Anstrom KJ; Perfect JR; Reller LB
    J Clin Microbiol; 2007 Mar; 45(3):698-706. PubMed ID: 17202279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida species.
    Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
    J Clin Microbiol; 2001 Nov; 39(11):3952-4. PubMed ID: 11682513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.
    Espinel-Ingroff A; Kerkering TM; Goldson PR; Shadomy S
    J Clin Microbiol; 1991 Jun; 29(6):1089-94. PubMed ID: 1864923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei.
    Chaturvedi V; Ramani R; Ghannoum MA; Killian SB; Holliday N; Knapp C; Ostrosky-Zeichner L; Messer SA; Pfaller MA; Iqbal NJ; Arthington-Skaggs BA; Vazquez JA; Sein T; Rex JH; Walsh TJ
    Antimicrob Agents Chemother; 2008 Apr; 52(4):1500-2. PubMed ID: 18227180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a spectrophotometric microdilution method with RPMI-2% glucose with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro susceptibility testing of amphotericin B, flucytosine, and fluconazole against Candida albicans.
    Rodríguez-Tudela JL; Berenguer J; Martínez-Suárez JV; Sanchez R
    Antimicrob Agents Chemother; 1996 Sep; 40(9):1998-2003. PubMed ID: 8878570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality control limits for voriconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue.
    Pfaller MA; Barry A; Bille J; Brown S; Ellis D; Meis JF; Rennie R; Rinaldi M; Rogers T; Traczewski M
    J Clin Microbiol; 2004 Apr; 42(4):1716-8. PubMed ID: 15071030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.
    Krishnarao TV; Galgiani JN
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1957-60. PubMed ID: 9303393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation.
    Odds FC; Vranckx L; Woestenborghs F
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2051-60. PubMed ID: 8540715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.